The survival difference between gastric cancer patients from the UK and Japan remains after weighted propensity score analysis considering all background factors

Abstract

Background Previous studies comparing survival between gastric cancer (GC) patients from the West and the East were based on the assumption that background factors and prognostic factors were identical. The aim of the current study was to compare the survival of GC patients from the UK and Japan using weighted propensity score analysis after identifying all different background factors. Methods Data from 464 patients from the Leeds Teaching Hospital NHS Trust, Leeds, UK (LTHT), and 465 patients from the Kanagawa Cancer Center Hospital, Yokohama, Japan (KCCH), who had surgery for GC were analyzed. Prognostic factors for overall survival (OS) and cancer-specific survival (CSS) were identified by univariate and multivariate analyses. Survival was compared by propensity score weighting after adjusting for all significantly different background factors. Results Most background factors were different between LTHT and KCCH patients. Unadjusted stage-specific OS and CSS were significantly better in KCCH. Independent prognostic factors for unadjusted OS and CSS were pT and pN in KCCH and in addition tumor location, pancreatectomy, resection margin status and number of examined lymph nodes in LTHT. Even after adjusting for all background characteristics, survival remained better in KCCH. Conclusions These results suggest that differences in background factors are unable to fully explain the survival difference of GC patients between UK and Japan. Comprehensive studies into the biology of GC and/or host factors are needed to fully understand the survival difference.

Surgical outcomes of laparoscopic distal gastrectomy compared to open distal gastrectomy: A retrospective cohort study based on a nationwide registry database in Japan

“…Also, the generalizability of our results to the population outside the PS matched cohorts (ie those with dominant propensity for either LDG or ODG) is unwarranted. There might be disadvantageous conditions related to the incidence of complications in Western countries, such as patients with a higher body mass index and the greater proportion of patients who present at an advanced stage . The surgical outcomes of the present survey have been gradually established and refined since 1991, when Kitano et al first reported LDG in patients with GC in Japan.…”

Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward

“…Moreover, results with apatinib have been reported among Chinese patients. As a result of differences in the biologic background and treatment patterns between Eastern and Western patients with gastric cancer, 10 other studies should be awaited to confirm these data outside Asia.…”

High Hepsin expression predicts poor prognosis in Gastric Cancer

“…The majority of gastric cancer patients are diagnosed at advanced stage, due to lacking early detecting methods31. To date, the outcomes for gastric cancer patients with similar TNM stage can be very different because of the heterogeneity of this tumor, and the prognostic models for gastric cancer patients are largely relied on the TNM stage5.…”